Skip to main content
    T

    TransMedics Group Inc (TMDX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $92.21
    +0.83 (+0.91%)

    Market Cap: $3.17B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    TransMedics Group Inc (TMDX) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    TransMedics Group (TMDX) trades at 70.9x trailing earnings and 4.4x sales. Its P/S of 4.4x is below its 5-year median of 11.0x. Its forward P/E is 31.1x. The median P/E across 9 similar companies is 23.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 128.0% higher over the next year. Its free cash flow yield is 1.4%.

    MultipleValue
    P/E (trailing)70.9x
    Forward P/E31.1x
    Price to sales4.4x
    Price to book5.8x
    EV/EBITDA25.7x
    Price to FCF71.6x
    EV/FCF79.8x
    PEG0.9
    FCF yield1.4%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S4.4x11.0xN/A
    P/B5.8x12.6xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 3 of the 7 year ends shown that have a P/E, its P/E ranged from 52.2x in 2025 to 986.6x in 2023.

    Year endPriceP/EP/SP/B
    2025$121.6552.2x7.1x10.5x
    2024$62.3561.7x4.8x9.6x
    2023$78.93986.6x10.8x19.7x
    2022$61.72N/A19.7x10.5x
    2021$19.16N/A17.5x7.8x
    2020$19.90N/A19.1x5.2x
    2019$19.01N/A14.6x7.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About TMDX

    What is TMDX's forward P/E ratio?

    TransMedics Group has a forward P/E ratio of 31.1x.

    Is TMDX stock overvalued?

    GNG's valuation label for TMDX is Undervalued. Its P/E of 70.9x compares with a median of 23.8x across 9 similar companies.

    What is TMDX's price to sales ratio?

    TransMedics Group has a price to sales ratio of 4.4x.

    What is TMDX's PEG ratio?

    TransMedics Group has a PEG ratio of 0.9.